BCR Wealth Strategies LLC Trims Stake in Encompass Health Co. (NYSE:EHC)

BCR Wealth Strategies LLC reduced its position in shares of Encompass Health Co. (NYSE:EHC) by 30.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,671 shares of the company’s stock after selling 2,000 shares during the quarter. Encompass Health comprises about 0.2% of BCR Wealth Strategies LLC’s portfolio, making the stock its 17th biggest position. BCR Wealth Strategies LLC’s holdings in Encompass Health were worth $431,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of EHC. MassMutual Private Wealth & Trust FSB boosted its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares in the last quarter. UMB Bank n.a. boosted its position in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares in the last quarter. V Square Quantitative Management LLC boosted its position in Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after acquiring an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new stake in Encompass Health during the 3rd quarter valued at $40,000. Finally, Tompkins Financial Corp bought a new stake in Encompass Health during the 4th quarter valued at $46,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on EHC. Truist Financial reissued a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday. KeyCorp raised their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, Barclays raised their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $107.67.

Encompass Health Stock Performance

NYSE EHC opened at $99.37 on Wednesday. The stock has a 50-day simple moving average of $96.14 and a two-hundred day simple moving average of $95.41. The firm has a market capitalization of $10.01 billion, a P/E ratio of 22.28, a PEG ratio of 1.18 and a beta of 0.90. Encompass Health Co. has a fifty-two week low of $72.38 and a fifty-two week high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. On average, equities analysts forecast that Encompass Health Co. will post 4.76 earnings per share for the current year.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.